Niva Bupa is likely to be a beneficiary of the structural growth story of India’s under-penetrated health insurance market says ICICI Securities.
ICICI Securities initiates coverage on Niva Bupa with a Buy rating and a target price of Rs 90 based on 35 times FY27E earnings per share of Rs 2.6 (IFRS).
Niva Bupa has delivered standout growth in health insurance premiums with a ~40% CAGR between FY20-25 and is expected to continue high growth driven by a diversified channel.
The improved scale and assets under management of Niva Bupa should help improve margins and earnings growth.